Caribou Biosciences (CRBU) Research & Development (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Research & Development data on file, last reported at $20.6 million in Q1 2026.

• Research & Development for Q1 2026 came in at $20.6 million, down 41.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $94.5 million (down 28.34% YoY), and the FY2025 annual result was $109.4 million, down 15.92% from the prior year.
• Research & Development retreated to $20.6 million in Q1 2026 per CRBU's latest filing, from $23.8 million in the prior quarter.
• Over five years, Research & Development peaked at $35.5 million in Q1 2025 and troughed at $13.9 million in Q1 2022.
• A 5-year average of $26.7 million and a median of $26.5 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2026: Research & Development surged 84.64% in 2023, then plunged 41.99% in 2026.
• A 5-year view of Research & Development shows it stood at $25.7 million in 2022, then increased by 21.54% to $31.3 million in 2023, then fell by 2.61% to $30.5 million in 2024, then slipped by 21.83% to $23.8 million in 2025, then retreated by 13.45% to $20.6 million in 2026.
• Business Quant data shows CRBU's Research & Development at $20.6 million in Q1 2026, $23.8 million in Q4 2025, and $22.4 million in Q3 2025.